1119.0000 4.80 (0.43%)
NSE Aug 10, 2026 15:57 PM
Volume: 932.4K
 

1119.00
0.43%
Deven Choksey
Zydus Lifesciences is increasingly positioning itself as a differentiated specialty-led healthcare company with multiple long-term growth drivers beyond traditional generics.
Zydus Lifesciences Ltd. is trading above its 200 day SMA of 974.3
More from Zydus Lifesciences Ltd.
Recommended